Scholarlink

<p>Predicting disease-associated peptides is a challenging task in bioinformatics, mostly hindered by the lack of reliable negative datasets, leading to biased predictions. In this study, we propose a one-class classification approach that focuses exclusively on positive-labeled data. We employed three classifiers namely One-Class Support Vector Machines (OCSVM), Isolation Forest, and Autoencoders to classify disease-associated peptides, with Autoencoders yielding the best results. The Autoencoders trained on the positive dataset effectively differentiated the inliers from outliers which is further evaluated by mean reconstruction errors. Our method combines various sequence based features together. This framework provides an efficient solution for predicting disease-associated peptides that also overcomes the traditional binary classification approaches. To enhance interpretability and peptide prioritization, we introduce a new scoring metric Disease Peptide Anomaly Score (DPAS) which combines model-derived anomaly scores with feature importance values obtained using SHAP (SHapley Additive exPlanations). DPAS facilitates the ranking of peptides based on their likelihood of being disease-associated, offering a robust and interpretable approach for peptide biomarker discovery.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

DPAS: disease-associated peptide anomaly score for identifying pathogenic peptides via one-class learning

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月15日

查看全文
  • Zoya Khalid,
  • Razia Khalid,
  • Osman Ugur Sezerman

摘要

Predicting disease-associated peptides is a challenging task in bioinformatics, mostly hindered by the lack of reliable negative datasets, leading to biased predictions. In this study, we propose a one-class classification approach that focuses exclusively on positive-labeled data. We employed three classifiers namely One-Class Support Vector Machines (OCSVM), Isolation Forest, and Autoencoders to classify disease-associated peptides, with Autoencoders yielding the best results. The Autoencoders trained on the positive dataset effectively differentiated the inliers from outliers which is further evaluated by mean reconstruction errors. Our method combines various sequence based features together. This framework provides an efficient solution for predicting disease-associated peptides that also overcomes the traditional binary classification approaches. To enhance interpretability and peptide prioritization, we introduce a new scoring metric Disease Peptide Anomaly Score (DPAS) which combines model-derived anomaly scores with feature importance values obtained using SHAP (SHapley Additive exPlanations). DPAS facilitates the ranking of peptides based on their likelihood of being disease-associated, offering a robust and interpretable approach for peptide biomarker discovery.